ARTICLE
16 June 2023

Holland & Knight Health Dose: June 13, 2023

HK
Holland & Knight

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
The U.S. House of Representatives and U.S. Senate are both in session. There are several hearings and markups across the House and Senate.
United States Food, Drugs, Healthcare, Life Sciences

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

  • This Week: House and Senate Hold Hearings on HHS' Priorities and Healthcare-Related Bills
  • House Ways and Means Committee Advances Telehealth Legislation
  • Senate Finance Committee Holds Consolidation Hearing
  • CDC in the House's Hot Seat
  • Bicameral Request for Information of Drug Shortages Released
  • House Appropriations Committee Resumes Markups After Delays
  • CMS Launches New Primary Care Model
  • FDA Addresses Chemotherapy Shortage
  • CMS Holds Health Equity Conference
  • CMS Releases New List of Drugs Subject to Inflationary Rebate
  • HHS Announces Pediatric Specialty Loan Repayment Program

Read the full Health Dose ยป

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More